Aristeia Capital’s Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 ACII.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-390,895
Closed -$18K 724
2022
Q3
$18K Hold
390,895
﹤0.01% 601
2022
Q2
$49K Hold
390,895
﹤0.01% 517
2022
Q1
$129K Buy
+390,895
New +$174K ﹤0.01% 511

Aristeia Capital's ACII.WS Position: Q4 2022 in Review

Aristeia Capital sold out of Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 (ACII.WS) in Q4 2022, closing a stake of 390,895 shares — an estimated $18K sold.

Aristeia Capital first reported a position in ACII.WS in Q1 2022 and held it in 3 quarters. The position peaked at $129K in Q1 2022. 0 funds tracked by Wall St. Rank hold ACII.WS as of Q4 2022.

  • Aristeia Capital reported no remaining Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position as of Q4 2022 after selling out during the quarter.
  • Aristeia Capital sold 390,895 Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 shares in Q4 2022, an estimated $18K.
  • Aristeia Capital first reported a position in Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 in Q1 2022 and held it in 3 quarters.
  • Aristeia Capital's Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 position peaked at $129K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held Atlas Crest Investment Corp. II Redeemable Warrants, each whole warrant exercisable for one Class A common stock at an exercise price of $11.50 as of Q4 2022.

Based on Aristeia Capital's 13F filing for Q4 2022, filed 14 Feb 2023.